Alpenglow Biosciences

Alpenglow Biosciences

Private
Seattle, WashingtonHealthcare & Life Scienceshttps://alpenglowbiosciences.com

Last Round

VC Round

Aug 15, 2024

Total Funding Raised

$8.12M

Momentum Score

25 /100

Company Overview

Alpenglow Biosciences is a life sciences company that provides a 3D spatial biology platform using AI-enabled imaging technology to accelerate drug development and improve clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Medical Imaging, Biotech Equipment, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Hardware + Subscription, Hardware Sales

AI Layer

Application

Keywords

3d spatial biology3d histologylight-sheet microscopyai image analysis3d digital pathologywhole block imagingcomputational pathologycro servicesdrug developmentimaging platformnon-destructive imaging3d tissue imagingclinical diagnosticsvolumetric pathologyimmuno-oncologycontract research services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Alpenglow Biosciences Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Alpenglow Biosciences Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundAug 15, 2024
GrantAug 15, 2024
GrantAug 1, 2023
GrantApr 11, 2022
GrantSep 20, 2021
Series A
Jun 15, 2021

Key People

Founding team and executive leadership

Nicholas Reder

Chief Executive Officer

Executive Team

Alpenglow Biosciences Investors

Notable investors and investment history

InvestorRounds
Dynamk CapitalSeries A, VC Round
NIH RADxGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 25, 2026

    Finalist for Innovation of the Year at the 2026 GeekWire Awards.

  • Mar 25, 2026

    Named a finalist for the Innovation of the Year award.

Alpenglow Biosciences Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Alpenglow Biosciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Alpenglow Biosciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeattle, Washington
Employee Range30
Year Founded2018
Last FundingAug 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.